✦ LIBER ✦

Sustained antiviral response and lack of viral resistance with long term adefovir dipivoxil (ADV) therapy in chronic HBV infection

✍ Scribed by Elizabeth Heathcote; Lennox Jeffers; Robert Perrillo; Teresa Wright; Morris Sherman; Hamid Namini; Shelly Xiong; Craig James; Victoria Ho; John Fry; Carol Brosgart

Book ID: 118565307
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 224 KB
Volume: 36
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(02)80391-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of long-term adefovi

Safety and efficacy of long-term adefovir dipivoxil (ADV) for lamivudine-resistant (LAM-R) HBV in HIV infected patients

✍ Yves Benhamou; M. Bochet; V. Thibault; V. Calvez; M.H. Fievet; Mark Sullivan; Ca 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB

1158 Long term treatment with adefovir d

1158 Long term treatment with adefovir dipivoxil (ADV) for three years in patients with lamivudine-resistant (LAM-R) HBV and HIV co-infection results in significant and sustained clinical improvement

✍ BENHAMOU, Y; THIBAULT, V; VIG, P; VALANTIN, M; GUYON, P; KATLAMA, C; LU, B; CURR 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

521 Long-term antiviral therapy with lam

521 Long-term antiviral therapy with lamivudine (LAM) and salvage adefovir dipivoxil (ADV) improves the outcome of patients with HBeAg-negative chronic hepatitis B (CHBe-)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Long-term efficacy of entecavir therapy

Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir

✍ M. S. Kwak; J. W. Choi; J. S. Lee; K. A. Kim; J. H. Suh; Y. S. Cho; S. Y. Won; B 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Sa1060 Long-Term Assessment of Hepatocel

Sa1060 Long-Term Assessment of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients With Sustained Viral Response to Antiviral Therapy

✍ Wang, Chun-Hsiang; Chang, Kuo-Kwen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Clinical course and predictive factors o

Clinical course and predictive factors of virological response in long-term lamivudine plus adefovir dipivoxil combination therapy for lamivudine-resistant chronic hepatitis B patients

✍ Mashu Aizawa; Akihito Tsubota; Kiyotaka Fujise; Keiko Tatsuzawa; Midori Kono; Sa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## Abstract The aims of this study were to assess the long‐term efficacy of lamivudine (LAM) plus adefovir dipivoxil (ADV) combination therapy in patients with chronic hepatitis B resistant to LAM, to identify predictive factors of complete viral response (HBV‐DNA <2.6 log copies/ml at 12 months of